Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

2.

Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.

Leo E, Welsh K, Matsuzawa S, Zapata JM, Kitada S, Mitchell RS, Ely KR, Reed JC.

J Biol Chem. 1999 Aug 6;274(32):22414-22.

4.

CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase.

Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, Morimoto C, Ware CF, Malinin NL, Wallach D, Yagita H, Okumura K.

J Biol Chem. 1998 May 22;273(21):13353-8.

6.
7.
12.

The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.

Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM, Choi Y.

J Biol Chem. 1998 Oct 23;273(43):28355-9.

14.

High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.

Pullen SS, Labadia ME, Ingraham RH, McWhirter SM, Everdeen DS, Alber T, Crute JJ, Kehry MR.

Biochemistry. 1999 Aug 3;38(31):10168-77.

PMID:
10433725
15.

TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB.

Lee SW, Han SI, Kim HH, Lee ZH.

J Biochem Mol Biol. 2002 Jul 31;35(4):371-6.

PMID:
12296995
17.

ASK1 is essential for JNK/SAPK activation by TRAF2.

Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K, Ichijo H.

Mol Cell. 1998 Sep;2(3):389-95.

18.

Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.

Hostager BS, Haxhinasto SA, Rowland SL, Bishop GA.

J Biol Chem. 2003 Nov 14;278(46):45382-90.

19.

Supplemental Content

Support Center